DSY Dassault Systemes SA

Dassault Systemes to Publish its Fourth Quarter and Full Year 2020 Results, Webcast and Conference Call on February 4th, 2021

Dassault Systemes to Publish its Fourth Quarter and Full Year 2020 Results, Webcast and Conference Call on February 4th, 2021

 

VÉLIZY-VILLACOUBLAY, France — January 21st, 2021 — (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, will publish its operating performance for the fourth quarter and full year 2020 ended December 31st, 2020 on Thursday, February 4th, 2021.

The management of Dassault Systèmes will host a webcast at 10.00 am Paris time – 09.00 am London time, and will then also host a conference call at 9:00 am New York time - 3:00 pm Paris time - 2:00 pm London time.

Both the webcast and the conference call will be available live and as replay on Dassault Systèmes’ investor website at .

We recommend that you connect at least fifteen minutes prior to each event to register, download and install any necessary software. The webcast and conference call will be archived for a year.

###

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual experience twins of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production. Dassault Systèmes brings value to more than 270,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit

3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, EXALEAD, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Systèmes, a French “société européenne” (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval.

Dassault Systèmes Investor Relations Team                                FTI Consulting

François-José Bordonado /Béatrix Martinez:                                Arnaud de Cheffontaines: 48

24/70 21                                                                Rob Mindell: 0

USA & Canada:

Attachment



EN
21/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Dassault Systemes SA

Dassault Systemes Sa: 2 directors

Two Directors at Dassault Systemes Sa bought 30,495 shares at between 24.530EUR and 24.661EUR. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...

 PRESS RELEASE

Update: Dassault Systèmes: Medidata Extends Collaboration with Sanofi ...

Update: Dassault Systèmes: Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey  Expanded 10-plus-year collaboration will leverage Medidata Experiences with the goal of streamlining clinical processes and data, enhancing patient care New York – Oct. 23, 2025 –, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an extension of their collaboration w...

 PRESS RELEASE

Mise à jour : Dassault Systèmes : Medidata étend sa collaboration avec...

Mise à jour : Dassault Systèmes : Medidata étend sa collaboration avec Sanofi pour développer de nouvelles thérapies visant à améliorer le parcours patient Medidata étend sa collaboration avec Sanofi pour développer de nouvelles thérapies visant à améliorer le parcours patient Une collaboration de plus de dix ans renforcée autour des Medidata Experiences, a pour l’objectif d’optimiser les processus et les données cliniques en améliorant la prise en charge des patients. New York, le 23 octobre 2025 – , marque de Dassault Systèmes et leader des solutions numériques pour les essais cliniques...

 PRESS RELEASE

Mise à jour : Dassault Systèmes : Sanofi renforce sa collaboration ave...

Mise à jour : Dassault Systèmes : Sanofi renforce sa collaboration avec Medidata pour accélérer le développement de nouvelles thérapies et améliorer le parcours patient Sanofi renforce sa collaboration avec Medidata pour accélérer le développement de nouvelles thérapies et améliorer le parcours patient Une collaboration de plus de dix ans élargie autour des Medidata Experiences, permettant à Sanofi d’optimiser ses opérations, d’affiner la qualité de ses données et d’améliorer la prise en charge des patients. New York, le 23 octobre 2025 – , marque de Dassault Systèmes et leader des soluti...

 PRESS RELEASE

Update: Dassault Systèmes: Medidata Extends Collaboration with Sanofi ...

Update: Dassault Systèmes: Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey  Expanded 10-plus-year collaboration will leverage Medidata Experiences with the goal of streamlining clinical processes and data, enhancing patient care New York – Oct. 23, 2025 –, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an extension of their collaboration w...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch